Long-term follow-up of imatinib for CML; Ocrelizumab for primary progressive multiple sclerosis

06.13.2017 - By UpToDate Talk

Download our free app to listen on your phone

This episode features Dr. Richard Larson discussing the long-term outcomes of imatinib treatment for chronic myeloid leukemia, and Dr. Francisco Gonzalez-Scarano discussing the use of ocrelizumab for treatment of primary progressive multiple sclerosis. Dr. Jennifer Mitty hosts.

More episodes from UpToDate Talk